Quercetin: A molecule with great biochemical, clinical and nutritional value
More details
Hide details
Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Thessaloniki, Greece
Publication date: 2022-05-27
Public Health Toxicol 2022;2(Supplement Supplement 1):A143
Quercetin, in general, belongs to the broader category of polyphenols. It is found, in particular, among the flavonols, along with kampferol, myricetin and isoramnetin and it is recognized as a foreign substance by the organism in contrast to vitamins. It occurs mainly linked to sugars with the most common compound being quercetin-3-O-glucoside, or as an aglycone, especially in the plant population. The aim of this review is to present the molecule of quercetin and the recent bibliography in the chemical field, on the mechanisms of absorption and metabolism, the bioavailability, the antioxidant and the clinical effect on diabetes, cancer and the coronavirus infection.

Databases such as Scopus, PubMed, Science Direct and Google Scholar were used to collect the sources.

Recent literature reports a positive effect of quercetin on coronavirus patients, as well as it provides a protective effect against oxidative stress, cancer and helps with the regulation of blood sugar levels. Moreover, research-administered drug dosages of up to 2000mg per day showed mild to no symptoms of overdose. It should be noted, that quercetin is not considered a carcinogen substance. The daily intake of quercetin through the diet has been measured from 10mg-500mg, depending on the type of products consumed.

Due to the lack of recent literature, a specific daily energy need for this substance has not been determined. Therefore, further studies must take place in order for the right administered quantity of quercetin to be considered beneficial to the body.

Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26(8):1001-1043. doi:10.1039/b802662a
Di Pierro F, Iqtadar S, Khan A, et al. Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. Int J Gen Med. 2021;14:2807-2816. doi:10.2147/IJGM.S318949
Han MK, Barreto TA, Martinez FJ, Comstock AT, Sajjan US. Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2020;7(1):e000392. doi:10.1136/bmjresp-2018-000392
Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Nutrients. 2016;8(3):167. doi:10.3390/nu8030167
Luo E, Zhang D, Luo H, et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China. Chin Med. 2020;15(1):34. doi:10.1186/s13020-020-00317-x
Moalin M, van Strijdonck GP, Bast A, Haenen GR. Competition between ascorbate and glutathione for the oxidized form of methylated quercetin metabolites and analogues: tamarixetin, 4'O-methylquercetin, has the lowest thiol reactivity. J Agric Food Chem. 2012;60(36):9292-9297. doi:10.1021/jf302068v
Moon YJ, Wang L, DiCenzo R, Morris ME. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos. 2008;29(4):205-217. doi:10.1002/bdd.605
Nabavi SF, Russo GL, Daglia M, Nabavi SM. Role of quercetin as an alternative for obesity treatment: you are what you eat! Food Chem. 2015;179:305-310. doi:10.1016/j.foodchem.2015.02.006
Shi GJ, Li Y, Cao QH, et al. In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature. Biomed Pharmacother. 2019;109:1085-1099. doi:10.1016/j.biopha.2018.10.130
Tang SM, Deng XT, Zhou J, Li QP, Ge XX, Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604. doi:10.1016/j.biopha.2019.109604
Journals System - logo
Scroll to top